Skip to Content
Merck
  • Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function.

Age-related severity of focal ischemia in female rats is associated with impaired astrocyte function.

Neurobiology of aging (2011-12-14)
Danielle K Lewis, Kristen T Thomas, Amutha Selvamani, Farida Sohrabji
ABSTRACT

In middle-aged female rats, focal ischemia leads to a larger cortical infarction as compared with younger females. To determine if stroke-induced cytotoxicity in middle-aged females was associated with impaired astrocyte function, astrocytes were harvested and cultured from the ischemic cortex of young and middle-aged female rats. Middle-aged astrocytes cleared significantly less glutamate from media as compared with young female astrocytes. Furthermore, astrocyte-conditioned media from middle-aged female astrocytes induced greater migration of peripheral blood monocyte cells (PBMCs) and expressed higher levels of the chemoattractant macrophage inflammatory protein-1 (MIP-1). Middle-aged astrocytes also induced greater migration of neural progenitor cells (NPCs), however, their ability to promote neuronal differentiation of neural progenitor cells was similar to young astrocytes. In males, where cortical infarct volume is similar in young and middle-aged animals, no age-related impairment was observed in astrocyte function. These studies show that the aging astrocyte may directly contribute to infarct severity by inefficient glutamate clearance and enhanced cytokine production and suggest a cellular target for improved stroke therapy among older females.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
QCM Chemotaxis Cell Migration Assay, 96-well (8 µm), fluorimetric, The QCM 8 uM 96-well Migration Assay utilizes a 8 um pore size, which is appropriate for leukocyte migration.
Sigma-Aldrich
QCM Chemotaxis Cell Migration Assay, 96-well (3 µm), fluorimetric, The Chemicon QCM 3 uM 96-well Migration Assay provides a quick & efficient system for quantitative determination of various factors on cell migration, including screening of pharmacological agents or evaluation of integrins.